Contemporary secondary prevention in survivors of ST-elevation myocardial infarction with and without chronic kidney disease: a retrospective analysis.
Christiane M EngelbertzJannik FeldLena MakowskiStefan A LangeChristian GünsterPatrik DrögeThomas RuhnkeJoachim GerßHolger ReineckeJeanette KöppePublished in: Clinical kidney journal (2023)
An improved long-term guideline-recommended drug therapy after STEMI regardless of renal impairment might lead to beneficial effects on long-term mortality.
Keyphrases
- st elevation myocardial infarction
- chronic kidney disease
- percutaneous coronary intervention
- end stage renal disease
- st segment elevation myocardial infarction
- cardiovascular events
- young adults
- coronary artery disease
- acute coronary syndrome
- risk factors
- emergency department
- cardiovascular disease
- peritoneal dialysis
- bone marrow
- mesenchymal stem cells